Open Innovation platform for Stem cell, Protein & Drug Discovery Researchers for scientific breakthroughs, collaborations and philanthropism, ...
What is BioPortfolio?
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to source core information on specific bio-related topics, to collate relevant data associated with each topic and to point the user to relevant knowledge resources.
We publish up to the minute news and regularly update content across our information databases.
BioPortfolio By The Numbers:
- 450,000 page views per month
- 400,000 unique visitors per month
- 600 press releases posted daily
- 100,000 medical terms
- 35,000 companies
- 700,000 press releases
- 90,000 clinical trials
- 6,000 drugs
|july 2011,déjà 14948 résultats à explorer pour l'été sur WORDPRESS.com! en cherchant immunology, mais 0 avec cytometry!, 1 avec cytomics, 5463 avec hematology, 0 avec leukemia, 41523 avec tuberculosis, 6250 avec assim, 4677 with SFI (strong future international?) , 1208 avec iuis... but many not relevant = intra uterine immunization, 143 avec ICSU (relevant)|
A Network to Promote Clinically Oriented Research in the Field of Tuberculosis in Europe by Sharing and Developing Ideas and Research Protocols
TBNET is a network of mostly European, research oriented clinicians, microbiologists, mycobacteriologists and epidemiologists interested in the field of tuberculosis and mycobacterial diseases. It was founded in 2006 by a self-organised group of pneumologists, epidemiologists and specialists in infectous dieseases in Copenhagen.
The goal of the TBNET is to promote clinically oriented research in the field of tuberculosis in Europe by sharing and developing ideas and research protocols among the members of the network. These goals have been approached by the conduction of observational cohort studies In the future, a clinical database will be established and cohort studies as well as prospective clinical trials will be performed.